However, you do not need to wait weeks to feel the medication working: many patients report reduced cravings and smaller portion sizes within days of the first dose, even if the scale doesn't move immediately
"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomized, phase 3 trial." Lancet
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines genetic predispositions in key peptide pathways, including GLP1R rs6923761, which may help provide context for how your body processes GLP-1 receptor signaling
If you prefer podcasts, listen to episodes All About Vitamin B12 Part 1 and Part 2
extended vs
Moreover, IF decreases neuroinflammation and oxidative stress, which are two significant factors contributing to neuronal damage and the advancement of neurodegenerative diseases [75, 77]